The ability of the Contact Lens Dry Eye Questionnaire (CLDEQ)-8 to detect ocular surface alterations in contact lens wearers.


Journal

Contact lens & anterior eye : the journal of the British Contact Lens Association
ISSN: 1476-5411
Titre abrégé: Cont Lens Anterior Eye
Pays: England
ID NLM: 9712714

Informations de publication

Date de publication:
06 2019
Historique:
received: 26 04 2018
revised: 17 07 2018
accepted: 20 11 2018
pubmed: 1 12 2018
medline: 18 4 2020
entrez: 1 12 2018
Statut: ppublish

Résumé

To study whether some ocular surface alterations could be associated with contact lens (CL) wearers suffering from CL discomfort (CLD) detected using the Contact Lens Dry Eye Questionnaire (CLDEQ)-8. Forty-one soft CL wearers further classified into symptomatic CL wearers (SCLW) and asymptomatic CL wearers (ACLW) by the CLDEQ-8, and 20 non CL wearers (NCLW) were included. Tear osmolarity, slit-lamp biomicroscopy findings, tear film break-up time, corneal and conjunctival staining, and Schirmer test were performed 24 h after CL removal. Data were compared among groups using the analysis of variance and the Student t-test or the Kruskal-Wallis H and the Mann-Whitney U tests, applying the Bonferroni correction. Correlations between the CLDEQ-8 and the clinical signs were performed using the Spearman correlation coefficient. Twenty-four SCLW, 17 ACLW and 20 NCLW were recruited. There were significant differences among groups for tear osmolarity (p < 0.001), limbal hyperaemia (p = 0.014), and tarsal hyperaemia (p = 0.031). Pairwise comparisons revealed that SCLW and ACLW had higher tear osmolarity (p < 0.003, both comparisons) and limbal hyperaemia (p = 0.027 and p = 0.048, respectively) than NCLW. Moreover, SCLW had higher tarsal hyperaemia (p = 0.030) than NCLW. No significant correlations were found (p > 0.05). The CLDEQ-8 was ineffective to detect clinical alterations between SCLW and ACLW; therefore, the use of questionnaires alone remains being the best approach to detect CLD. The role of the tarsal conjunctiva in the development of CLD should be analyzed in future studies.

Identifiants

pubmed: 30497902
pii: S1367-0484(18)30743-4
doi: 10.1016/j.clae.2018.11.012
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

273-277

Informations de copyright

Copyright © 2018 British Contact Lens Association. Published by Elsevier Ltd. All rights reserved.

Auteurs

Alberto López-de la Rosa (A)

Institute of Applied Ophthalmobiology (IOBA)-University of Valladolid, Valladolid, Spain; Department of Theoretical Physics, Atomic and Optics, University of Valladolid, Valladolid, Spain.

Cristina Arroyo-Del Arroyo (C)

Institute of Applied Ophthalmobiology (IOBA)-University of Valladolid, Valladolid, Spain; Department of Theoretical Physics, Atomic and Optics, University of Valladolid, Valladolid, Spain.

Amalia Enríquez-de-Salamanca (A)

Institute of Applied Ophthalmobiology (IOBA)-University of Valladolid, Valladolid, Spain; Networking Research Center on Bioengineering Biomaterials and Nanomedicine (CIBER-BBN), Valladolid, Spain.

José Pinto-Fraga (J)

Institute of Applied Ophthalmobiology (IOBA)-University of Valladolid, Valladolid, Spain; Networking Research Center on Bioengineering Biomaterials and Nanomedicine (CIBER-BBN), Valladolid, Spain.

Alberto López-Miguel (A)

Institute of Applied Ophthalmobiology (IOBA)-University of Valladolid, Valladolid, Spain; Redes temáticas de investigación cooperativa en salud (Oftared), Instituto de Salud Carlos III, Madrid, Spain.

María J González-García (MJ)

Institute of Applied Ophthalmobiology (IOBA)-University of Valladolid, Valladolid, Spain; Department of Theoretical Physics, Atomic and Optics, University of Valladolid, Valladolid, Spain; Networking Research Center on Bioengineering Biomaterials and Nanomedicine (CIBER-BBN), Valladolid, Spain. Electronic address: mjgonzalez@ioba.med.uva.es.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH